Oxidative-mechanical stress signals stem cell niche mediated Lrp5 osteogenesis in eNOS -/- null mice

Journal of Cellular Biochemistry

Volumn 113, Issue 5, 2012, Pages 1623-1634

  Rajamannan, Nalini M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

eNOS; LIPIDS; Lrp5; VALVULAR HEART DISEASE

Indexed keywords

ATORVASTATIN; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; TRANSCRIPTION FACTOR RUNX2; WNT3A PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANION EXCHANGE CHROMATOGRAPHY; AORTA STENOSIS; AORTA VALVE DISEASE; ARTICLE; BONE DEVELOPMENT; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; MECHANICAL STRESS; MOUSE; MYOFIBROBLAST; NONHUMAN; OSSIFICATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ISOLATION; STEM CELL;

ANIMALS; AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; CELL COMMUNICATION; CELL DIFFERENTIATION; CHOLESTEROL, DIETARY; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5; MICE; MICE, KNOCKOUT; MODELS, CARDIOVASCULAR; MYOFIBROBLASTS; NITRIC OXIDE SYNTHASE TYPE III; OSTEOGENESIS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; STEM CELL NICHE; STRESS, MECHANICAL; WNT3A PROTEIN;

MUS;

EID: 84859057951     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24031     Document Type: Article

References (44)

1. Agur Z, Daniel Y, Ginosar Y,. 2002. The universal properties of stem cells as pinpointed by a simple discrete model. J Math Biol 44: 79-86. (Pubitemid 44200142)
2. Aikawa E, Nahrendorf M, Sosnovik D, Lok VM, Jaffer FA, Aikawa M, Weissleder R,. 2007. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 115: 377-386. (Pubitemid 46148512)
3. Blair A, Shaul PW, Yuhanna IS, Conrad PA, Smart EJ,. 1999. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J Biol Chem 274: 32512-32519.
4. Caira FC, Stock SR, Gleason TG, McGee EC, Huang J, Bonow RO, Spelsberg TC, McCarthy PM, Rahimtoola SH, Rajamannan NM,. 2006. Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol 47: 1707-1712.
5. Chen AF, Jiang SW, Crotty TB, Tsutsui M, Smith LA, O'Brien T, Katusic ZS,. 1997. Effects of in vivo adventitial expression of recombinant endothelial nitric oxide synthase gene in cerebral arteries. Proc Natl Acad Sci USA 94: 12568-12573. (Pubitemid 27492569)
6. Chen JH, Yip CY, Sone ED, Simmons CA,. 2009. Identification and characterization of aortic valve mesenchymal progenitor cells with robust osteogenic calcification potential. Am J Pathol 174: 1109-1119.
7. de Haan G, Dontje B, Nijhof W,. 1996. Concepts of hemopoietic cell amplification. Synergy, redundancy and pleiotropy of cytokines affecting the regulation of erythropoiesis. Leuk Lymphoma 22: 385-394. (Pubitemid 26341004)
8. Drolet MC, Arsenault M, Couet J,. 2003. Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol 41: 1211-1217. (Pubitemid 36384911)
9. Feron O, Dessy C, Moniotte S, Desager JP, Balligand JL,. 1999. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 103: 897-905. (Pubitemid 29152636)
10. Garcia-Cardena G, Oh P, Liu J, Schnitzer JE, Sessa WC,. 1996. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: Implications for nitric oxide signaling. Proc Natl Acad Sci USA 93: 6448-6453. (Pubitemid 26230326)
11. Garcia-Cardena G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, Lisanti MP, Sessa WC,. 1997. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem 272: 25437-25440. (Pubitemid 27438846)
12. Hassler C, Cruciat CM, Huang YL, Kuriyama S, Mayor R, Niehrs C,. 2007. Kremen is required for neural crest induction in Xenopus and promotes LRP6-mediated Wnt signaling. Development 134: 4255-4263.
13. Hurlstone AF, Haramis AP, Wienholds E, Begthel H, Korving J, Van Eeden F, Cuppen E, Zivkovic D, Plasterk RH, Clevers H,. 2003. The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature 425: 633-637. (Pubitemid 37280148)
14. Kirton JP, Crofts NJ, George SJ, Brennan K, Canfield AE,. 2007. Wnt/beta-catenin signaling stimulates chondrogenic and inhibits adipogenic differentiation of pericytes: Potential relevance to vascular disease? Circ Res 101: 581-589. (Pubitemid 351325875)
15. Kovar JL, Simpson MA, Schutz-Geschwender A, Olive DM,. 2007. A systematic approach to the development of fluorescent contrast agents for optical imaging of mouse cancer models. Anal Biochem 367: 1-12. (Pubitemid 46938663)
16. Lee TC, Zhao YD, Courtman DW, Stewart DJ,. 2000. Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation 101: 2345-2348. (Pubitemid 30329122)
17. Liu AC, Joag VR, Gotlieb AI,. 2007. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol 171: 1407-1418. (Pubitemid 350158303)
18. Makkena B, Salti H, Subramaniam M, Thennapan S, Bonow RH, Caira F, Bonow RO, Spelsberg TC, Rajamannan NM,. 2005. Atorvastatin decreases cellular proliferation and bone matrix expression in the hypercholesterolemic mitral valve. J Am Coll Cardiol 45: 631-633. (Pubitemid 40222262)
19. Mohler ER 3rd, Chawla MK, Chang AW, Vyavahare N, Levy RJ, Graham L, Gannon FH,. 1999. Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis 8: 254-260. (Pubitemid 29274326)
20. Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS,. 2001. Bone formation and inflammation in cardiac valves. Circulation 103: 1522-1528. (Pubitemid 32226259)
21. Osman L, Yacoub MH, Latif N, Amrani M, Chester AH,. 2006. Role of human valve interstitial cells in valve calcification and their response to atorvastatin. Circulation 114: I547-I552. (Pubitemid 44297206)
22. Paruchuri S, Yang JH, Aikawa E, Melero-Martin JM, Khan ZA, Loukogeorgakis S, Schoen FJ, Bischoff J,. 2006. Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2. Circ Res 99: 861-869. (Pubitemid 44556385)
23. Rajamannan NM,. 2011a. Bicuspid aortic valve disease: The role of oxidative stress in Lrp5 bone formation. Cardiovasc Pathol 3: 168-176.
24. -/- mice. J Cell Biochem 112: 2987-2991.
25. Rajamannan NM,. 2011c. The Role of Lrp5/6 in cardiac valve disease: LDL-density-pressure theory. J Cell Biochem 112: 2222-2229.
26. Rajamannan NM, Helgeson SC, Johnson CM,. 1988. Anionic growth factor activity from cardiac valve endothelial cells: Partial purification and characterization. Clin Res 36: 309A.
27. Rajamannan NM, Caplice N, Anthikad F, Sebo TJ, Orszulak TA, Edwards WD, Tajik J, Schwartz RS,. 2001a. Cell proliferation in carcinoid valve disease: A mechanism for serotonin effects. J Heart Valve Dis 10: 827-831. (Pubitemid 33133581)
28. Rajamannan NM, Sangiorgi G, Springett M, Arnold K, Mohacsi T, Spagnoli LG, Edwards WD, Tajik AJ, Schwartz RS,. 2001b. Experimental hypercholesterolemia induces apoptosis in the aortic valve. J Heart Valve Dis 10: 371-374. (Pubitemid 32454760)
29. Rajamannan NM, Springett MJ, Pederson LG, Carmichael SW,. 2002a. Localization of caveolin 1 in aortic valve endothelial cells using antigen retrieval. J Histochem Cytochem 50: 617-628.
30. Rajamannan NM, Subramaniam M, Springett M, Sebo TC, Niekrasz M, McConnell JP, Singh RJ, Stone NJ, Bonow RO, Spelsberg TC,. 2002b. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 105: 2260-2265.
31. Rajamannan NM, Edwards WD, Spelsberg TC,. 2003a. Hypercholesterolemic aortic-valve disease. N Engl J Med 349: 717-718.
32. Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan J, Springett M, Orszulak T, Fullerton DA, Tajik AJ, Bonow RO, Spelsberg T,. 2003b. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 107: 2181-2184. (Pubitemid 36547209)
33. Rajamannan NM, Subramaniam M, Caira F, Stock SR, Spelsberg TC,. 2005a. Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation 112: I229-I234. (Pubitemid 41266679)
34. Rajamannan NM, Subramaniam M, Stock SR, Stone NJ, Springett M, Ignatiev KI, McConnell JP, Singh RJ, Bonow RO, Spelsberg TC,. 2005b. Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart 91: 806-810. (Pubitemid 40769233)
35. Rajamannan NM, Evans FJ, Aikawa E, Grande-Allen KJ, Demer LL, Heistad DD, Simmons CA, Masters KS, Mathieu P, O'Brien KD, Schoen FJ, Towler DA, Yoganathan AP, Otto CM,. 2011. Calcific aortic valve disease: Not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update. Circulation 124: 1783-1791.
36. Roberts WC, Ko JM,. 2005. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 111: 920-925. (Pubitemid 40279895)
37. Shah V, Haddad FG, Garcia-Cardena G, Frangos JA, Mennone A, Groszmann RJ, Sessa WC,. 1997. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J Clin Invest 100: 2923-2930. (Pubitemid 28007564)
38. Shah V, Toruner M, Haddad F, Cadelina G, Papapetropoulos A, Choo K, Sessa WC, Groszmann RJ,. 1999. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. Gastroenterology 117: 1222-1228. (Pubitemid 29512682)
39. Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP, Towler DA,. 2005. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 115: 1210-1220. (Pubitemid 40629039)
40. Stringa E, Filanti C, Giunciuglio D, Albini A, Manduca P,. 1995. Osteoblastic cells from rat long bone. I. Characterization of their differentiation in culture. Bone 16: 663-670.
41. Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Bostrom K, Demer LL,. 2003. Multilineage potential of cells from the artery wall. Circulation 108: 2505-2510. (Pubitemid 37444413)
42. Wada T, McKee MD, Steitz S, Giachelli CM,. 1999. Calcification of vascular smooth muscle cell cultures: Inhibition by osteopontin. Circ Res 84: 166-178. (Pubitemid 29070112)
43. Weiss RM, Ohashi M, Miller JD, Young SG, Heistad DD,. 2006. Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation 114: 2065-2069. (Pubitemid 44706883)
44. Westerlind KC, Wronski TJ, Ritman EL, Luo ZP, An KN, Bell NH, Turner RT, Turner RT,. 1997. Estrogen regulates the rate of bone turnover but bone balance in ovariectomized rats is modulated by prevailing mechanical strain. Proc Natl Acad Sci USA 94: 4199-4204. (Pubitemid 27180523)